Leber’s congenital amaurosis – Life with Disease

Go back

Leber’s congenital amaurosis is a rare inherited eye disease affecting the retina, causing severe vision loss or blindness from birth or early infancy. Understanding the long-term outlook and how this condition shapes daily life can help families prepare for the journey ahead.

Prognosis and Long-Term Outlook

When parents receive the diagnosis of Leber’s congenital amaurosis for their child, one of their first questions is naturally about what the future holds. This condition represents one of the most challenging inherited eye diseases, and understanding its expected course helps families make informed decisions and prepare emotionally for what lies ahead.[1]

The outlook for children with Leber’s congenital amaurosis varies depending on several factors, but the general pattern involves severe visual impairment that begins at birth or becomes apparent within the first few months of life. About one in three babies with this condition is born completely blind, while others have very poor vision that they can initially use to some degree.[2] This early and profound vision loss distinguishes Leber’s congenital amaurosis from many other eye conditions that develop later in childhood or adulthood.

Over time, the vision that remains typically continues to decline. Most individuals with Leber’s congenital amaurosis will experience progressive loss of sight as they grow older. The final visual acuity rarely reaches better than what doctors measure as 20/400, which means that what a person with normal vision can see clearly at 400 feet, someone with this level of vision loss would need to be just 20 feet away to see with the same clarity. In fact, approximately one-third of people with this condition eventually have no perception of light at all.[7]

However, there is an important variation in how quickly vision deteriorates and how much sight might be preserved. Some forms of Leber’s congenital amaurosis, particularly those linked to specific genetic changes, may progress more slowly than others. In rare cases, individuals may experience periods where their vision actually improves temporarily before the overall downward trend continues.[8] These variations make it difficult to predict precisely how any individual child’s vision will change over the years.

⚠️ Important
Recent advances in gene therapy have begun to change the outlook for some patients with specific genetic forms of Leber’s congenital amaurosis, particularly those with mutations in the RPE65 gene. This treatment can improve vision in eligible patients, though it does not completely restore normal sight. Parents should discuss with their child’s eye specialist whether their child might be a candidate for such therapies.[5]

Life expectancy itself is not typically affected by Leber’s congenital amaurosis when the condition affects only the eyes. The disease primarily impacts vision rather than overall health or lifespan. However, it’s important to note that some genetic variations causing Leber’s congenital amaurosis can occasionally affect other body systems, including the kidneys or cause developmental delays. In such cases, the overall health picture becomes more complex and requires monitoring by specialists beyond eye care providers.[3]

Natural Progression Without Treatment

Understanding how Leber’s congenital amaurosis develops naturally, without intervention, helps families grasp what to expect and why early detection matters. The condition follows a pattern that begins at the genetic level, long before a baby is even born. The genetic changes that cause this disease affect how the retina develops and functions.[2]

The retina is the specialized tissue at the back of the eye that works much like the film in a traditional camera, capturing light and converting it into electrical signals that the brain interprets as images. In healthy eyes, special cells called photoreceptors perform this critical light-sensing function. Leber’s congenital amaurosis disrupts the normal development or function of these photoreceptors, which means the retina cannot properly process light from the very beginning of life or soon after birth.[8]

During the first few months of an affected baby’s life, parents often begin noticing that something is different about their child’s vision. The baby may not make eye contact, may not seem to follow moving objects or faces with their gaze, and may only respond to very bright lights or windows. These early signs reflect the fact that the retina is already functioning poorly or not at all.[4]

As the child grows, other characteristic features typically emerge. Many young children with Leber’s congenital amaurosis develop a habit of pressing, rubbing, or poking their eyes with their fingers or knuckles. This behavior, known clinically as the oculo-digital reflex or Franceschetti’s sign, occurs because pressing on the eyes stimulates the remaining photoreceptor cells to produce sensations of flashing lights called phosphenes. While this gives the child some form of visual stimulation, the repeated pressure can contribute to the deep-set or sunken appearance of the eyes that often develops over time.[1]

The retina itself may initially appear relatively normal when examined by an eye doctor, which can sometimes delay diagnosis. However, a special test called an electroretinogram, or ERG, reveals the true extent of the problem. This test measures the electrical activity in the retina, and in Leber’s congenital amaurosis, the results show very little or no electrical response, described as a “flat” ERG. This finding is one of the hallmarks of the condition.[8]

As months and years pass, the retina begins to show visible changes. The light-sensing cells continue to degenerate, meaning they break down and die. The blood vessels that supply the retina become narrower and thinner than normal. Areas of abnormal pigmentation may appear, creating a spotted or mottled appearance. The optic nerve, which carries signals from the eye to the brain, may become pale, indicating damage. These changes reflect the ongoing deterioration of the visual system.[8]

Other eye problems commonly develop alongside the retinal changes. Many individuals with Leber’s congenital amaurosis develop extreme farsightedness, meaning they would need very strong glasses to see clearly if their retinas were working properly. The pupils, which normally expand in darkness and contract in bright light, often respond sluggishly or not at all to changes in lighting. Involuntary rapid eye movements called nystagmus are common, as are eyes that don’t align properly with each other, a condition called strabismus.[1]

In some cases, the cornea—the clear front surface of the eye—can become cone-shaped, a condition known as keratoconus. Clouding of the lens, called cataracts, may also occur. These additional problems can further reduce whatever limited vision might have remained.[3]

One concerning aspect of the natural progression involves sensitivity to light, called photophobia. Despite having such poor vision, many individuals with Leber’s congenital amaurosis find bright lights uncomfortable or even painful. This paradox can be particularly challenging for families to understand and manage in daily life.[6]

Possible Complications

Beyond the primary vision loss that defines Leber’s congenital amaurosis, several complications can arise that affect both the eyes and, in some cases, other aspects of health. Understanding these potential complications helps families watch for warning signs and seek appropriate care when needed.

The physical changes to the eyes themselves can lead to additional problems. The development of keratoconus, where the cornea becomes thin and bulges outward into a cone shape, can cause distorted vision and discomfort. In severe cases, the cornea can become scarred or even rupture, requiring specialized treatment or transplantation. The cataracts that sometimes develop can cloud vision further, though surgical removal is possible if deemed beneficial.[4]

The persistent habit of pressing or rubbing the eyes, while understandable as a way for children to create visual sensations, can cause its own set of problems. Beyond contributing to the sunken appearance of the eyes, repeated trauma to the eye structures could potentially worsen existing problems or create new injuries. However, this behavior is deeply rooted in the way the condition affects visual perception, making it extremely difficult for children to stop even when parents try to discourage it.[3]

Some genetic forms of Leber’s congenital amaurosis are associated with problems beyond the eyes. Certain gene mutations can affect kidney function, requiring monitoring by a pediatrician or nephrologist. Developmental delays have been reported in some cases, though it remains uncertain whether these delays result directly from the genetic changes or from the challenges of growing up with severe vision loss. Some children may experience hearing impairment, epilepsy, or difficulties with motor skill development.[4][8]

⚠️ Important
Not all children with Leber’s congenital amaurosis will experience problems beyond vision loss. The genetic form of the disease determines whether other organ systems might be affected. Genetic testing and counseling can help families understand which specific complications to watch for in their child’s case, allowing for appropriate monitoring and early intervention when needed.[8]

There is also concern about emotional and psychological complications. Because vision loss is present from such an early age, children with Leber’s congenital amaurosis may become socially isolated. They cannot see the faces of other children, making it harder to form connections. They may be teased or excluded from activities that other children take for granted. These social challenges can lead to feelings of loneliness, frustration, or sadness that require attention and support.[17]

Some experts note that delayed development reported in very rare cases might actually be preventable or minimized through early intervention. Providing blind or visually impaired children with rich opportunities to play, explore through touch and hearing, and engage in age-appropriate learning activities can help prevent developmental delays. This underscores the importance of not attributing every challenge automatically to the genetic condition itself when environmental factors and early support can make a meaningful difference.[1]

Impact on Daily Life

Living with Leber’s congenital amaurosis profoundly shapes every aspect of daily existence, from the earliest years through adulthood. The degree of impact varies depending on how much functional vision remains, but even small amounts of light perception can be meaningful for navigation and orientation in familiar environments.

For babies and toddlers with the condition, parents face unique challenges in helping their child develop normally despite the vision loss. Simple activities that sighted children learn through observation—reaching for objects, crawling toward interesting sights, recognizing faces—require different approaches for children who cannot see. Early intervention programs become crucial, teaching parents how to encourage their child’s development through touch, sound, and other senses. These programs help children learn to move confidently through space, understand their environment, and develop the foundational skills needed for later independence.[13]

As children grow older and begin school, the challenges evolve. Reading and writing require learning Braille or using audio materials and technology. Getting around school safely means learning mobility skills, sometimes with a white cane or eventually a guide dog. Participating in sports or playground activities requires creativity and adaptation. Many children report feeling different from their peers and struggling with the desire to fit in while also needing accommodations that make them stand out.[17]

The emotional impact of living with Leber’s congenital amaurosis cannot be overstated. Children and adults with this condition face daily reminders of what they cannot do. They cannot drive, which affects independence and social opportunities, particularly in areas without reliable public transportation. Career choices may be limited by vision requirements. Simple pleasures like watching movies, admiring nature, or seeing the faces of loved ones are inaccessible or severely limited. Some individuals describe feeling frustrated when they receive excessive praise for ordinary tasks or when others express pity, both of which can feel demeaning.[17]

Daily practical challenges include navigating unfamiliar environments, reading signs and labels, managing personal care, preparing food safely, and accessing printed information that isn’t available in alternative formats. Technology has opened new doors—screen readers, voice assistants, and GPS navigation apps help with many tasks—but these tools require training and aren’t always available or affordable.[13]

Social relationships can be affected in multiple ways. Making eye contact, a cornerstone of social interaction in many cultures, is impossible. Reading facial expressions and body language requires other strategies. Dating and forming romantic relationships bring additional anxieties about disclosure and acceptance. Starting families raises questions about passing the condition to children, since Leber’s congenital amaurosis is inherited.[17]

Employment presents both challenges and opportunities. With appropriate accommodations and assistive technology, many individuals with Leber’s congenital amaurosis work successfully in various fields. However, finding employers willing to make necessary adjustments and overcoming assumptions about what blind or severely visually impaired people can do requires persistence and advocacy. Job training programs and vocational rehabilitation services exist to help, though access to these resources varies by location.[17][18]

Mobility is a central concern throughout life. Learning to travel safely and independently using a white cane, guide dog, or other aids requires extensive training. Public transportation systems vary widely in accessibility. In rural or suburban areas with limited transit options, dependence on others for transportation can feel like a significant loss of freedom and spontaneity.[13]

Despite these challenges, many individuals with Leber’s congenital amaurosis describe living fulfilling lives. They emphasize that having vision loss from birth or early childhood means they’ve never known life differently, which can make adaptation more natural than it might be for someone who loses vision later. They develop strong skills in their remaining senses, build meaningful relationships, pursue education and careers, and find joy and purpose. The key factors that support positive outcomes include early intervention, strong family support, access to assistive technology and training, and a supportive community that focuses on abilities rather than disabilities.[17]

Support for Families Considering Clinical Trials

For families of children with Leber’s congenital amaurosis, the possibility of participating in clinical trials represents hope for treatments that might preserve or even improve vision. Understanding what clinical trials involve and how families can support their loved ones through this process is an important part of exploring all available options.

Clinical trials are research studies designed to test whether new treatments are safe and effective. For Leber’s congenital amaurosis, many current trials focus on gene therapy—treatments that attempt to correct or compensate for the faulty genes causing the condition. The development of voretigene neparvovec-rzyl (Luxturna), the first gene therapy approved for a specific form of Leber’s congenital amaurosis caused by RPE65 mutations, came about through clinical trials that showed meaningful vision improvements in participants.[5][10]

Families should understand that clinical trials have different phases, each with specific purposes. Early phase trials focus primarily on safety, testing whether a treatment causes harmful side effects. Later phases test effectiveness and compare new treatments to existing options. Participation criteria are often strict—trials may only accept patients with specific genetic mutations, within certain age ranges, or who retain particular amounts of retinal tissue. Not every child with Leber’s congenital amaurosis will qualify for every trial.[12]

When considering clinical trial participation, families benefit from thoroughly understanding what involvement entails. Trials require multiple visits to specialized medical centers, which may be far from home. Procedures can be invasive—gene therapy for Leber’s congenital amaurosis typically involves surgery to inject the therapeutic agent under the retina. Follow-up appointments and testing may continue for months or years. There are no guarantees of benefit, and some participants may receive placebo treatments as part of the research design.[12]

Relatives play a crucial role in helping patients navigate clinical trial opportunities. Parents can start by ensuring their child receives genetic testing to identify the specific mutation causing their Leber’s congenital amaurosis. This information determines which trials might be relevant. They can research available trials through registries and communicate with their child’s ophthalmologist about potential matches. Keeping detailed medical records and having recent test results readily available streamlines the screening process when trial opportunities arise.[11]

Emotional support is equally important as logistical help. Participating in a clinical trial can bring hope, but also anxiety about procedures, disappointment if not accepted, or frustration if the treatment doesn’t work as hoped. Family members should be prepared to discuss these feelings openly, helping patients maintain realistic expectations while still feeling supported in their decision to try.[12]

Several recent advances have created optimism for new treatment options. Gene therapies targeting different mutations beyond RPE65 are under development. Researchers are exploring therapies for LCA5, LCA10 caused by CEP290 mutations, and LCA4 caused by AIPL1 mutations, among others. Some of these experimental treatments have shown promising results in early trials, with children who were nearly completely blind gaining functional vision for the first time.[11]

Families should also be aware that clinical trial results contribute to scientific knowledge even when individual participants don’t experience dramatic improvements. Each person who participates helps researchers understand more about the disease and refine future treatments. This broader impact can provide meaning to families, knowing they’re contributing to advances that may help others in the future.

Financial considerations matter when contemplating clinical trial participation. While the experimental treatment itself is typically provided at no cost, families may still incur expenses for travel, lodging, meals, and time away from work. Some trials offer stipends or reimbursement for these costs, but not all do. Families should inquire about financial support options before committing to participation.

Finding reliable information about available clinical trials requires knowing where to look. Major research institutions, patient advocacy organizations like the Foundation Fighting Blindness, and government registries maintain databases of ongoing studies. Connecting with other families affected by Leber’s congenital amaurosis through support groups can provide firsthand insights about trial experiences and recommendations.[11]

💊 Registered drugs used for this disease

Based on the provided information, the following gene therapy has been approved for treatment of specific forms of this condition:

  • Voretigene neparvovec-rzyl (Luxturna™) – The first gene therapy approved by the U.S. Food and Drug Administration to treat a genetic disease. It is used specifically for Leber congenital amaurosis caused by mutations in both copies of the RPE65 gene. The therapy is injected underneath the retina during a surgical procedure to deliver a functional copy of the gene to appropriate retinal cells, and has been shown to improve vision in patients with this specific genetic form of the disease.

Ongoing Clinical Trials on Leber’s congenital amaurosis

  • Study on the Effectiveness and Safety of Sepofarsen for Patients with Leber Congenital Amaurosis Due to a Specific Genetic Mutation

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany The Netherlands Spain

References

https://medlineplus.gov/genetics/condition/leber-congenital-amaurosis/

https://my.clevelandclinic.org/health/diseases/24167-lebers-congenital-amaurosis

https://www.fightingblindness.org/diseases/leber-congenital-amaurosis-lca

https://www.ucsfhealth.org/conditions/leber-congenital-amaurosis-lca

https://www.asrs.org/patients/retinal-diseases/37/leber-congenital-amaurosis-lca

https://rarediseases.info.nih.gov/diseases/634/leber-congenital-amaurosis

https://disorders.eyes.arizona.edu/disorders/leber-congenital-amaurosis

https://www.asrs.org/patients/retinal-diseases/37/leber-congenital-amaurosis-lca

https://my.clevelandclinic.org/health/diseases/24167-lebers-congenital-amaurosis

https://pmc.ncbi.nlm.nih.gov/articles/PMC2839440/

https://www.fightingblindness.org/news/leber-congenital-amaurosis-research-advances-861

https://www.chop.edu/stories/gene-therapy-inherited-blindness-hannah-s-leber-congenital-amaurosis-story

https://www.guidedogs.org.uk/getting-support/information-and-advice/eye-conditions/leber-congenital-amaurosis/

https://my.clevelandclinic.org/health/diseases/24167-lebers-congenital-amaurosis

https://www.asrs.org/patients/retinal-diseases/37/leber-congenital-amaurosis-lca

https://www.fightingblindness.org/diseases/leber-congenital-amaurosis-lca

https://hopeinfocus.org/living-with-lca-it-does-no-good-to-have-pity/

https://www.guidedogs.org.uk/getting-support/information-and-advice/eye-conditions/leber-congenital-amaurosis/living-with-leber-congenital-amaurosis

https://www.ucsfhealth.org/conditions/leber-congenital-amaurosis-lca

FAQ

Is Leber’s congenital amaurosis the same as retinitis pigmentosa?

While related, they are not exactly the same. Some retinal experts consider Leber’s congenital amaurosis to be a severe form of retinitis pigmentosa (RP) that begins at birth or in early infancy. Both conditions involve photoreceptor degeneration and can be caused by mutations in overlapping genes, but Leber’s congenital amaurosis causes much more severe vision loss much earlier in life than typical RP.

Will my child with Leber’s congenital amaurosis be able to go to regular school?

Yes, many children with Leber’s congenital amaurosis attend regular schools with appropriate support and accommodations. They will likely need to learn Braille, use assistive technology, and receive orientation and mobility training. Early intervention programs and educational support services help children develop the skills they need to succeed academically despite severe vision loss.

Can gene therapy cure Leber’s congenital amaurosis?

Current gene therapy does not cure the condition but can improve vision in some patients with specific genetic mutations. The approved gene therapy Luxturna works only for patients with mutations in the RPE65 gene, which accounts for about 6% of cases. While it doesn’t completely restore normal vision, it has been shown to provide meaningful improvement that is stable for at least several years. Researchers are working to develop gene therapies for other genetic forms of the disease.

How is Leber’s congenital amaurosis inherited?

Leber’s congenital amaurosis is almost always inherited in an autosomal recessive pattern. This means a child must inherit two copies of the mutated gene—one from each parent—to develop the condition. Parents who carry only one copy typically have no vision problems themselves and may be unaware they carry the mutation. Each child of two carrier parents has a 25% chance of having the condition.

Why does my child rub their eyes so much if they can’t see?

Eye rubbing or pressing is a characteristic behavior in Leber’s congenital amaurosis called the oculo-digital reflex. When children press on their eyes, it stimulates the remaining photoreceptor cells to produce sensations of light flashes. This provides some form of visual stimulation even when functional vision is absent. While understandable, repeated eye pressing may contribute to the sunken appearance eyes develop over time.

🎯 Key takeaways

  • Leber’s congenital amaurosis causes severe vision loss from birth or early infancy, with about one-third of affected babies born completely blind and most others having vision that progressively worsens over time.
  • The condition results from mutations in at least 19 to 30 different genes, all affecting how light-detecting cells in the retina develop and function, which is why genetic testing is crucial for accurate diagnosis.
  • A characteristic sign is children pressing or rubbing their eyes with their fingers or knuckles (Franceschetti’s oculo-digital sign), which occurs because the pressure creates sensations of flashing lights.
  • Gene therapy is now available for patients with mutations in the RPE65 gene and has been shown to provide meaningful vision improvement, representing the first FDA-approved gene therapy for any inherited disease.
  • Early intervention programs that provide rich sensory experiences through touch, hearing, and other non-visual senses can help prevent developmental delays in children with the condition.
  • With appropriate support, assistive technology, mobility training, and educational resources, many individuals with Leber’s congenital amaurosis live fulfilling lives and pursue education, careers, and meaningful relationships.
  • Multiple promising gene therapies targeting different genetic forms of the disease are currently in clinical trials, offering hope for future treatment options beyond the currently approved RPE65 therapy.
  • Some genetic forms may affect organs beyond the eyes, including kidneys and neurological development, making comprehensive medical evaluation and monitoring important for affected children.

Connected medications: